Summary Δ 9-tetrahydrocannabinol (THC) and its sibling, cannabidiol (CBD), are produced
by the same Cannabis plant and have similar chemical structures but differ dramatically in …

The rise in cannabinoid legalization and decriminalization in the US has been paired with
an increase in adolescents that perceive marijuana as a “no risk” drug. However, a …

At present, clinical interest in the plant-derived cannabinoid compound cannabidiol (CBD) is
rising exponentially, since it displays multiple therapeutic properties. In addition, CBD can …

The process of memory entails the activation of numerous neural networks and biochemical
pathways throughout the brain. The phenomenon of memory decline in relation to aging has …

Protein kinase C (PKC) isozymes are members of the Serine/Threonine kinase family
regulating cellular events following activation of membrane bound phospholipids. The …

Cognitive impairments are common in patients with schizophrenia. Changes in total
cholesterol (TC) may be involved in the development of schizophrenia and associated with …

Endometriosis is a chronic painful disease highly prevalent in women that is defined by
growth of endometrial tissue outside the uterine cavity and lacks adequate treatment …

A growing body of literature suggests that cannabis intake can induce memory loss in
humans and animals. Besides the recreational use, daily cannabis users may also belong to …

Intellectual disability is the most limiting hallmark of Down syndrome, for which there is no
gold-standard clinical treatment yet. The endocannabinoid system is a widespread …

Cannabis legalization continues to progress in many US states and other countries. Δ 9-
tetrahydrocannabinol (Δ 9-THC) is the major psychoactive constituent in cannabis …